Skip to content
Search

Latest Stories

Three Essex pharmacies set for new beginnings

Three well-established pharmacies were sold in Essex in just three days
Longfield Pharmacy in Maldon, Essex

There’s high demand for pharmacies in Essex and the Northern Home Counties

In just three days, three well-established pharmacies were sold in Essex —Dips Chemist and Riverview Pharmacy in Grays, and Longfield Pharmacy in Maldon.

According to specialist business property adviser Christie and Co, Dips Chemist and Riverview Pharmacy were included in a wider portfolio sale following their entry into administration in 2023.


Both pharmacies, which collectively dispense an average of circa 14,000 items per month, have been acquired by Primary Health Solutions Ltd, an independent pharmacy operator led by Husain Master.

“These two pharmacies are the perfect addition to my existing portfolio,” said Master, who plans to increase the services offered as well as invest in the pharmacies to create a more clinical and welcoming environment.

Mark Page, director - Pharmacy at Christie and Co, highlighted that there’s an appetite for a full range of pharmacies in Essex and the Northern Home Counties, with many buyers looking to take on well-performing pharmacies or purchase a quieter pharmacy that can be improved.

In a separate transaction, the broker recently announced the sale of Longfield Pharmacy in Maldon.

Owned by Esom’s Ltd since 2017, the pharmacy was brought to market to facilitate the semi-retirement of its owner, Vijay Mistry.

The new owners are a group of friends—Tauqir Hassan, Muhammad Munir, Waseem Syed, and Shaheryar Alam—who own a small growing group, called Pharmazone Ltd, in Essex.

Situated within a busy health centre in Maldon, Longfield Pharmacy dispenses an average of 15,163 items per month, aided by a state-of-the-art dispensing robot.

“A glass panel allows patients to watch as their prescription is plucked off the shelf by the robot arm and dropped into a bag,” Page said.

“The new owners are experienced pharmacy operators in the area and will continue to build on the good work done by Vijay and the team already,” he added.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less